Olumiant Baricitinib 2mg Tablets
Olumiant Baricitinib 2mg Tablets

Olumiant Baricitinib 2mg Tablets

MOQ : 10 Pieces

Olumiant Baricitinib 2mg Tablets Specification

  • Origin of Medicine
  • Imported (manufacturer not specified)
  • Indication
  • Rheumatoid Arthritis, other autoimmune conditions as per physician
  • Brand Name
  • Olumiant
  • Salt Composition
  • Baricitinib 2mg
  • Pacakaging (Quantity Per Box)
  • Not clearly legible, refer to pack
  • Life Span
  • Check expiry date on packaging
  • Dosage Form
  • Tablet
  • Packaging Type
  • Blister pack
  • Drug Type
  • Allopathic
  • Ingredients
  • Baricitinib
  • Physical Form
  • Tablet
  • Function
  • Janus kinase (JAK) inhibitor, reduces inflammation
  • Recommended For
  • Adults with moderate to severe rheumatoid arthritis
  • Dosage
  • As prescribed by a physician; commonly 2mg once daily
  • Dosage Guidelines
  • Take orally, do not crush or chew, follow doctors advice
  • Suitable For
  • Adults
  • Quantity
  • Not specified on image
  • Storage Instructions
  • Store below 30C, protect from moisture and light
  • Registration/Approval
  • Approved by regulatory authorities in multiple countries
  • Therapeutic Class
  • Immunosuppressant
  • Prescription Required
  • Yes
  • Shelf Life
  • As mentioned on pack; do not use after expiry
  • Caution
  • Use under medical supervision; not recommended in patients with severe hepatic impairment or active infections
  • Market Availability
  • Available in Canada, Europe, UK, USA, Australia
  • Colour
  • Film-coated, white tablet
  • Administration Route
  • Oral
  • Patient Advice
  • Consult doctor before use if pregnant, lactating, or having existing health conditions
 
 

Olumiant Baricitinib 2mg Tablets About



Olumiant Baricitinib 2mg Tablets are in demand among medical professionals for their masterful efficacy in managing moderate to severe rheumatoid arthritis. These first-rate, film-coated white tablets unlock relief by targeting Janus kinase pathways, reducing inflammation effectively. Available in Canada, Europe, the UK, USA, and Australia, Olumiant must be taken orally as prescribed by a physician. Its excellent track record, regulatory approvals, and prescription control ensure optimal safety for adult patients. Caution is crucial: use only under medical supervision, especially if you have hepatic impairment, active infections, or are pregnant/lactating. Store below 30C, away from moisture.

Extra Features, Clinical Applications & Specific Usage

Olumiant Baricitinib 2mg Tablets offer broad utility across commercial and hospital settings as an advanced immunosuppressant. Designed for adults, these tablets are indicated for rheumatoid arthritis and, as advised, for other autoimmune disorders. Their blister-pack format ensures each dose is protected and fresh. Patients are guided to take the tablet whole, not crushed or chewed, for maximal efficacy. Strict adherence to physician guidance ensures the best therapeutic outcome and minimizes risk of side effects.


Payment Dynamics, Regulatory Approvals & Supply Provisions

The market value of Olumiant is bolstered by its extensive certifications and regulatory approvals across several key regions. Payment terms and outlay options vary and are finalized with the supplier, ensuring flexibility for healthcare providers. With robust transport services, reliable supply chains support consistent product availability. Each batch meets stringent quality standards, and supply ability remains high due to strong manufacturer partnerships and active global distribution routes.


FAQ's of Olumiant Baricitinib 2mg Tablets:


Q: How should Olumiant Baricitinib 2mg Tablets be taken for best results?

A: Olumiant tablets should be taken orally, swallowed whole with water, and exactly as prescribed by your physician. Do not crush or chew the tablet. Always follow your doctor's dosage guidelines for optimal results.

Q: What conditions can Olumiant Baricitinib 2mg Tablets treat?

A: Olumiant is primarily recommended for adults with moderate to severe rheumatoid arthritis, but it may also be prescribed for other autoimmune diseases as determined by your physician.

Q: When should you avoid taking Olumiant Baricitinib?

A: Avoid using Olumiant if you have severe hepatic impairment, active infections, or are pregnant or lactating, unless otherwise directed by a healthcare provider. Always consult your doctor about any pre-existing medical conditions before starting treatment.

Q: Where is Olumiant Baricitinib 2mg commercially available?

A: Olumiant is approved and available in Canada, Europe, the UK, USA, and Australia through prescription-based supply.

Q: What benefits does Olumiant provide as a Janus kinase (JAK) inhibitor?

A: Olumiant delivers relief by inhibiting Janus kinase activity, reducing the inflammation associated with autoimmune conditions, thereby helping patients regain mobility and comfort.

Q: How should Olumiant Baricitinib Tablets be stored to maintain their quality?

A: Store the tablets below 30C, protected from moisture and light, and never use them beyond the expiry date indicated on the packaging.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email



Back to top